Gondola Mechanism of Action
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Chronic Stroke, Cerebral Palsy, Parkinson's Disease
In brief
This study will investigate the clinical, functional and neurophysiological effects of automated mechanical peripheral stimulation (AMPS) via the Gondola device administered to patients with chronic stroke, cerebral palsy and Parkinson's Disease. Results will be collected using standardized outcome measures and a transcranial magnetic stimulation assessment protocol including electrical stimulation and electromyographic recording.
Key facts
- Study ID
- NCT05146648
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 0
- Starts
- 2023-01-12
- Expected to finish
- 2023-01-12
- Last updated by the study team
- 2023-01-18
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- age 18 to 80;
- chronic stroke lesion >6 months after a cerebrovascular accident OR diagnosis of cerebral palsy OR Parkinson's Disease;
- presence of some degree of motor function in the ankle flexor (Soleus motor power >1);
- able to ambulate 10 meters without physical assistance.
You may not qualify if…
- medically unstable condition;
- presence of other concurrent neurological illness;
- cognitive impairment (Montreal Cognitive Assessment score <23);
- presence of any potential TMS risk factor: damaged skin at the site of stimulation;
- presence of an electrically, magnetically or mechanically activated implant, an intracerebral vascular clip, or any other electrically sensitive support system;
- family history of medication-resistant epilepsy;
- past history of seizures or unexplained spells of loss of consciousness.
Where it is running
- Abilities Research Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.